eMarketer says weight loss drug brands online need clear pricing and ongoing personal care if they want to hold on to patients.
Recap by typeshit. Full story at eMarketer.
Fifteen drugs, from Ozempic and Wegovy to Trelegy Ellipta, get Medicare negotiated prices that take effect January 1, 2027.
Analysts led by Yang Huang expect about 15% yearly growth, citing the large diabetes and obesity burden across the three countries.
A guide covers who qualifies for the lower price, how to bring it up with a doctor, and delivery options that cut costs further.
A Facebook post says Ozempic's Medicare price drops 71% as negotiated rates on 15 drugs, including Wegovy and Trelegy, take effect.
Researchers in Granada report that combining intermittent fasting and exercise over 12 weeks improved fat loss and fitness in adults with obesity.
Hanmi says the WHO listed an international nonproprietary name for its next obesity candidate, following its earlier drug efpeglenatide.
Loading…